Depletion of CD8+ T cells, NK cells, and both CD8+ T cells and NK cells completely abrogated the anti-tumor efficacy of N-803 + αPD-L1 (Additional file 1: Figure S5A,B). This evidence concerns the gene CD8A and neoplasm.